Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.

Antimicrobial agents and chemotherapy - 1 Aug 2004

Mushtaq Shazad, Ge Yigong, Livermore David M

Abstract excerpt

Doripenem is a broad-spectrum parenteral carbapenem under clinical development in Japan and North America. Its activities against (i) Pseudomonas aeruginosa isolates with graded levels of intrinsic efflux-type resistance, (ii) mutants with various combinations of AmpC and OprD expression, (iii) PU21 transconjugants with class A and D beta-lactamases, and (iv) P. aeruginosa isolates with metallo-beta-lactamases...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Outer Membrane Proteins
Share to beta-Lactamases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carbapenems

Share to Conjugation, Genetic

Share to Drug Resistance, Bacterial

Share to Electrophoresis, Polyacrylamide Gel

Share to Pseudomonas aeruginosa

Share to Pseudomonas Infections

Source

Open in PubMed Open full text

Identifiers

PMID: 15273124
DOI: 10.1128/AAC.48.8.3086-3092.2004
PMCID: PMC478525

Genes

VIM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.PMID 15273124Read ↗

Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.Semantic proximity Read ↗

Comparative pharmacodynamics and antimutant potentials of doripenem and imipenem with ciprofloxacin-resistant Pseudomonas aeruginosa in an in vitro model.Semantic proximity Read ↗

Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosaSemantic proximity Read ↗

Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.Semantic proximity Read ↗

C-Terminal Region of Pseudomonas aeruginosa Outer Membrane Porin OprD Modulates Susceptibility to MeropenemSemantic proximity Read ↗

OprD mutations and inactivation in imipenem-resistant Pseudomonas aeruginosa isolates from China.Semantic proximity Read ↗

AmpC induction by imipenem in Pseudomonas aeruginosa occurs in the absence of OprD and impacts imipenem/relebactam susceptibilitySemantic proximity Read ↗

Impact of meropenem exposure on fluoroquinolone and carbapenem resistance in Pseudomonas aeruginosa infection in inpatients in a Japanese university hospital: Insights into oprD mutations and efflux pump overexpression.Semantic proximity Read ↗

Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.Semantic proximity Read ↗

Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.Semantic proximity Read ↗

The Overexpression of AmpC is Not Required but May Contribute to Imipenem/Relebactam Non-susceptibilitySemantic proximity Read ↗

OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.